Get the Stockscreener App
5.78
3.03%
0.17
Iovance Biotherapeutics Inc Stock (IOVA) Forecast
The Iovance Biotherapeutics Inc (IOVA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $29.70, representing a +413.89% increase from the current price of $5.78. The highest analyst price target is $35.92, and the lowest is $23.49.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month IOVA Price Target
Average 37.04
(+540.85% Upside)
Is Iovance Biotherapeutics Inc (IOVA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 44.96 | Neutral |
| STOCH(9,6) | 51.13 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.2964 | Buy |
| ADX(14) | 29.71 | Sell |
| William %R | -34.23 | Neutral |
| CCI(14) | 56.94 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
5.515
Buy
|
5.6341
Buy
|
| MA20 |
5.77
Buy
|
5.8019
Sell
|
| MA50 |
6.61
Sell
|
6.6105
Sell
|
| MA100 |
8.1885
Sell
|
7.5895
Sell
|
| MA200 |
8.8413
Sell
|
8.3807
Sell
|
Buy: 3
Sell: 7
Neutral: 0
Summary: Sell
According to our latest analysis, IOVA could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 9 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on IOVA, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 44.96 indicates that IOVA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 51.13 indicates that IOVA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that IOVA is oversold. This suggests that IOVA price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 29.71 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 56.94 indicates that IOVA is still overbought but not to an extreme extent.
Long-term IOVA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Iovance Biotherapeutics Inc financial reports and earnings history, Iovance Biotherapeutics Inc (IOVA) stock could reach $23.60 by 2030, $11.16 by 2040 and $23.79 by 2050. See the projected annual prices until 2050 of the Iovance Biotherapeutics Inc stock below:
- Iovance Biotherapeutics Inc (IOVA) is expected to reach an average price of $8.9843 in 2035, with a high prediction of $9.1443 and a low estimate of $6.7192. This indicates an $55.44% rise from the last recorded price of $5.78.
- Iovance Biotherapeutics Inc (IOVA) stock is projected to chart a bullish course in 2040, with an average price target of $10.37, representing an $79.37% surge from its current level. The forecast ranges from a conservative $10.01 to a sky-high $11.16.
- Our analysts predict Iovance Biotherapeutics Inc (IOVA) to jump 176.65% by 2045, soaring from $15.37 to an average price of $15.99, potentially reaching $18.09. While $15.37 is the low estimate, the potential upside is significant.
- Iovance Biotherapeutics Inc (IOVA) stock is expected to climb by 2050, reaching an average of $23.75, a $310.93% jump from its current level. However, a wide range of estimates exists, with high and low targets of $23.79 and $19.85, respectively, highlighting the market's uncertainty.
Iovance Biotherapeutics Inc Stock (IOVA) Year by Year Forecast
Iovance Biotherapeutics Inc Stock (IOVA) Price Forecast for 2025
Iovance Biotherapeutics Inc Stock (IOVA) is expected to reach an average price of $31.56 in 2025, with a high prediction of $42.96 and a low estimate of $20.16. This indicates an +446.04% rise from the last recorded price of $5.78.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $33.41 | $23.49 | $35.92 | +478.01% |
| April, 2025 | $30.79 | $20.16 | $39.61 | +432.73% |
| May, 2025 | $38.26 | $28.55 | $38.56 | +562.02% |
| June, 2025 | $37.75 | $31.50 | $40.43 | +553.06% |
| July, 2025 | $31.42 | $29.70 | $42.96 | +443.60% |
| August, 2025 | $30.98 | $27.81 | $33.45 | +436.03% |
| September, 2025 | $30.70 | $28.22 | $33.85 | +431.06% |
| October, 2025 | $32.13 | $28.98 | $35.95 | +455.85% |
| November, 2025 | $34.40 | $30.98 | $38.41 | +495.17% |
| December, 2025 | $37.23 | $26.27 | $40.23 | +544.19% |
Iovance Biotherapeutics Inc Stock (IOVA) Price Forecast for 2026
The predicted value for Iovance Biotherapeutics Inc (IOVA) in 2026 is set at an average of $36.54. Estimates vary from a peak of $55.70 to a trough of $17.38, indicating an +532.21% surge from the present price of $5.78.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $40.87 | $36.65 | $43.08 | +607.03% |
| February, 2026 | $48.80 | $39.82 | $53.92 | +744.27% |
| March, 2026 | $52.55 | $45.02 | $55.70 | +809.20% |
| April, 2026 | $48.68 | $42.55 | $54.53 | +742.30% |
| May, 2026 | $32.86 | $30.51 | $48.21 | +468.46% |
| June, 2026 | $31.69 | $29.25 | $35.49 | +448.27% |
| July, 2026 | $27.32 | $26.00 | $35.05 | +372.71% |
| August, 2026 | $24.96 | $17.38 | $29.26 | +331.75% |
| September, 2026 | $28.14 | $23.85 | $29.51 | +386.83% |
| October, 2026 | $25.04 | $22.53 | $28.51 | +333.24% |
| November, 2026 | $25.58 | $21.70 | $26.08 | +342.62% |
| December, 2026 | $26.17 | $22.97 | $27.52 | +352.71% |
Iovance Biotherapeutics Inc Stock (IOVA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Iovance Biotherapeutics Inc (IOVA) is $18.60, with a high forecast of $29.48 and a low forecast of $7.7225. This indicates an +221.81% increase from the last price of $5.78.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $27.13 | $25.45 | $29.48 | +369.36% |
| February, 2027 | $20.35 | $20.15 | $28.49 | +252.11% |
| March, 2027 | $21.00 | $17.47 | $21.13 | +263.41% |
| April, 2027 | $17.02 | $15.51 | $22.13 | +194.42% |
| May, 2027 | $17.40 | $14.81 | $18.79 | +201.04% |
| June, 2027 | $14.50 | $14.41 | $19.48 | +150.92% |
| July, 2027 | $18.19 | $13.71 | $19.87 | +214.63% |
| August, 2027 | $17.81 | $16.62 | $20.27 | +208.10% |
| September, 2027 | $8.5612 | $8.2912 | $18.68 | +48.12% |
| October, 2027 | $10.30 | $7.7225 | $11.01 | +78.27% |
| November, 2027 | $14.07 | $10.41 | $14.45 | +143.36% |
| December, 2027 | $14.21 | $12.54 | $14.99 | +145.84% |
Iovance Biotherapeutics Inc Stock (IOVA) Price Forecast for 2028
In 2028, Iovance Biotherapeutics Inc (IOVA) is projected to reach an average price of $10.86, with a high projection of $14.87 and a low estimate of $6.8558. This indicates an +87.94% rise from the last price of $5.78.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $12.53 | $11.90 | $14.87 | +116.81% |
| February, 2028 | $11.13 | $11.01 | $13.43 | +92.64% |
| March, 2028 | $10.90 | $9.9107 | $11.97 | +88.54% |
| April, 2028 | $7.7401 | $6.9794 | $11.17 | +33.91% |
| May, 2028 | $7.6832 | $7.3132 | $9.9819 | +32.93% |
| June, 2028 | $7.8357 | $7.1538 | $8.3657 | +35.57% |
| July, 2028 | $8.9282 | $8.0663 | $10.05 | +54.47% |
| August, 2028 | $7.7814 | $7.5264 | $9.1907 | +34.63% |
| September, 2028 | $7.5039 | $6.9576 | $8.507 | +29.82% |
| October, 2028 | $8.4264 | $6.8558 | $8.5674 | +45.79% |
| November, 2028 | $10.38 | $8.282 | $10.94 | +79.58% |
| December, 2028 | $8.6221 | $8.5121 | $10.49 | +49.17% |
Iovance Biotherapeutics Inc Stock (IOVA) Price Forecast for 2029
The 2029 price forecast for Iovance Biotherapeutics Inc Stock (IOVA) is $12.37 on average, with a high prediction of $19.94 and a low estimate of $4.8034. This represents an +114.02% increase from the previous price of $5.78.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $8.8452 | $8.3827 | $10.40 | +53.03% |
| February, 2029 | $7.7377 | $7.5677 | $9.5165 | +33.87% |
| March, 2029 | $6.8602 | $6.0002 | $8.0602 | +18.69% |
| April, 2029 | $5.2227 | $5.1477 | $7.7708 | -9.64% |
| May, 2029 | $5.5659 | $4.8034 | $6.2909 | -3.70% |
| June, 2029 | $7.8584 | $5.3965 | $8.1777 | +35.96% |
| July, 2029 | $9.7309 | $7.5996 | $10.63 | +68.35% |
| August, 2029 | $9.334 | $8.944 | $11.91 | +61.49% |
| September, 2029 | $17.38 | $9.2047 | $18.53 | +200.63% |
| October, 2029 | $16.63 | $15.21 | $19.94 | +187.71% |
| November, 2029 | $12.92 | $12.62 | $17.11 | +123.57% |
| December, 2029 | $13.93 | $12.68 | $14.61 | +141.00% |
Iovance Biotherapeutics Inc Stock (IOVA) Price Forecast for 2030
Iovance Biotherapeutics Inc Stock (IOVA) is expected to reach an average price of $27.09 in 2030, with a high forecast of $41.07 and a low forecast of $13.11. This signifies an +368.73% surge from the last price of $5.78.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $22.12 | $13.11 | $23.60 | +282.63% |
| February, 2030 | $26.80 | $21.65 | $28.37 | +363.69% |
| March, 2030 | $26.61 | $24.65 | $29.39 | +360.32% |
| April, 2030 | $23.76 | $22.18 | $26.58 | +311.10% |
| May, 2030 | $21.14 | $20.56 | $24.70 | +265.79% |
| June, 2030 | $23.46 | $20.68 | $24.01 | +305.93% |
| July, 2030 | $24.52 | $22.99 | $27.28 | +324.20% |
| August, 2030 | $32.29 | $24.76 | $32.30 | +458.72% |
| September, 2030 | $30.18 | $27.31 | $32.58 | +422.13% |
| October, 2030 | $26.80 | $24.26 | $29.15 | +363.59% |
| November, 2030 | $27.08 | $25.02 | $41.07 | +368.52% |
| December, 2030 | $31.31 | $21.62 | $36.91 | +441.61% |
0.27%
3.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):